Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Electromed (ELMD) Non-Current Deferred Tax Liability (2011 - 2024)

Electromed (ELMD) reported Non-Current Deferred Tax Liability of $651000.0 for Q2 2024, up 1.72% year-over-year from $640000.0 in Q3 2023, and up 1.72% on a QoQ basis from $640000.0 in Q2 2023.

Electromed (ELMD) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $651000.0 in Q2 2024.

  • Quarterly Non-Current Deferred Tax Liability rose 1.72% year-over-year to $651000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $651000.0 (up 1.72% YoY) and the FY2024 annual result came in at $651000.0, up 1.72% from the prior year.
  • Non-Current Deferred Tax Liability grew to $651000.0 in Q2 2024 per ELMD's latest filing, from $640000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $651000.0 in Q2 2024 and bottomed at $287000.0 in Q2 2022.
  • The 3-year median for Non-Current Deferred Tax Liability is $640000.0 (2023), against an average of $526000.0.
  • The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability jumped 123.0%; it then gained 1.72% in 2024.
  • Tracing ELMD's Non-Current Deferred Tax Liability over 3 years: stood at $287000.0 in 2022, then jumped by 123.0% to $640000.0 in 2023, then rose by 1.72% to $651000.0 in 2024.
  • Per Business Quant, the three latest ELMD Non-Current Deferred Tax Liability figures stand at $651000.0 (Q2 2024), $640000.0 (Q2 2023), and $287000.0 (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Electromed 300.53 Mn 283.55 Mn 14.64 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 651,000.00
Jun 30, 2024 651,000.00
Jun 30, 2023 640,000.00
Jun 30, 2023 640,000.00
Jun 30, 2022 287,000.00
Jun 30, 2022 287,000.00
Dec 31, 2013 103,000.00
Dec 31, 2013 103,000.00
Sep 30, 2013 103,000.00
Sep 30, 2013 103,000.00
Jun 30, 2013 103,000.00
Jun 30, 2013 103,000.00
Mar 31, 2013 280,000.00
Mar 31, 2013 280,000.00
Dec 31, 2012 280,000.00
Dec 31, 2012 280,000.00
Sep 30, 2012 280,000.00
Sep 30, 2012 280,000.00
Jun 30, 2012 280,000.00
Jun 30, 2012 280,000.00
Mar 31, 2012 167,000.00
Mar 31, 2012 167,000.00
Dec 31, 2011 167,000.00
Dec 31, 2011 167,000.00
Sep 30, 2011 167,000.00
Sep 30, 2011 167,000.00
Jun 30, 2011 167,000.00
Jun 30, 2011 167,000.00